Giovannoni G, et al. Cladribine tablets in high disease activity (HDA) subgroups from the CLARITY study of patients with relapsing multiple sclerosis (RMS). EP1157. EAN 2017.
Bundel met verhalen over jonge mensen met Parkinson
mrt 2019 | Bewegingsstoornissen